首页> 美国卫生研究院文献>Physiological Reports >Effects of solid‐phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet‐induced obese rats
【2h】

Effects of solid‐phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet‐induced obese rats

机译:固相提取血浆对瘦和饮食诱发的肥胖大鼠禁食和进食血液中肠道代谢激素的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glucagon‐like peptide‐1 (GLP‐1), peptide YY (3‐36) [PYY(3‐36)], amylin, ghrelin, insulin, and leptin are thought to act as hormonal signals from periphery to brain to control food intake. Here, we determined the effects of solid‐phase extraction of plasma in measuring these hormones in blood of lean and diet‐induced obese rats. Individual enzyme‐linked immunoassays and a multiplex assay were used to measure active GLP‐1, total PYY, active amylin, active ghrelin, insulin, leptin, and total GIP in response to (1) addition of known amounts of the peptides to lean and obese plasma, (2) a large meal in lean and obese rats, and (3) intravenous infusions of anorexigenic doses of GLP‐1, PYY(3‐36), amylin, and leptin in lean rats. Extraction of lean and obese plasma prior to assays produced consistent recoveries across assays for GLP‐1, PYY, amylin, ghrelin, and insulin, reflecting losses inherent to the extraction procedure. Plasma extraction prior to assays generally revealed larger meal‐induced changes in plasma GLP‐1, PYY, amylin, ghrelin, and insulin in lean and obese rats. Plasma extraction and the multiplex assay were used to compare plasma levels of GLP‐1, PYY, and amylin after a large meal with plasma levels produced by IV infusions of anorexigenic doses of GLP‐1, style="fixed-case">PYY(3‐36), and amylin. Infusions produced dose‐dependent increases in plasma peptide levels, which were well above their postprandial levels. These results do not support the hypothesis that postprandial plasma levels of style="fixed-case">GLP‐1, style="fixed-case">PYY(3‐36), and amylin are sufficient to decrease food intake by an endocrine mechanism.
机译:胰高血糖素样肽-1(GLP-1),肽YY(3-36)[PYY(3-36)],胰岛淀粉样多肽,生长素释放肽,胰岛素和瘦素被认为是从周围到大脑的激素信号,从而控制食物录取。在这里,我们确定了固相提取血浆对测量肥胖和饮食诱发的肥胖大鼠血液中这些激素的影响。响应于(1)向瘦肉和瘦肉中添加已知量的肽,使用单独的酶联免疫测定和多重测定来测量活性GLP-1,总PYY,活性胰岛淀粉样多肽,活性生长素释放肽,胰岛素,瘦素和总GIP。肥胖血浆;(2)肥胖和肥胖大鼠的大餐;(3)肥胖大鼠静脉输注厌食症剂量的GLP-1,PYY(3-36),胰岛淀粉样多肽和瘦素。在测定之前提取瘦和肥胖的血浆在测定中对GLP-1,PYY,胰岛淀粉样多肽,生长素释放肽和胰岛素的回收率一致,反映了提取程序固有的损失。测定前的血浆提取通常显示瘦和肥胖大鼠血浆中GLP-1,PYY,胰岛淀粉样多肽,生长素释放肽和胰岛素的粗粉诱导变化更大。血浆提取和多重分析用于比较大餐后GLP-1,PYY和胰岛淀粉样多肽的血浆水平与静脉输注厌食症剂量的GLP-1产生的血浆水平, style =“ fixed-case”> PYY (3-36)和胰岛淀粉样多肽。输注产生血浆肽水平的剂量依赖性增加,远高于餐后水平。这些结果不支持以下假设:餐后血浆水平 style =“ fixed-case”> GLP -1, style =“ fixed-case”> PYY (3-36)和胰岛淀粉样多肽通过内分泌机制足以减少食物摄入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号